SCHEMBL5287501

SCHEMBL5287501

N#C[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.62
▸ DNMT1 P26358 3/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ DNMT3B Q9UBC3 1/20 0.62
▸ PKM P14618 1/20 0.62
▸ MAPT P10636 6/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ TDP1 Q9NUW8 2/20 0.51
▸ STAT3 P40763 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ ADRB1 P08588 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ HTR1D P28221 1/20 0.46
▸ HTR1B P28222 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5287512 1.00 KMT2A (0.62) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL14625611 0.80 KMT2A (0.67) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL1600730 0.78 KMT2A (0.67) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL1600733 0.78 KMT2A (0.67) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL11949518 0.77 KMT2A (1.00) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL164192 0.77 KMT2A (1.00) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL30167914 0.77 KMT2A (1.00) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL562060 0.77 KMT2A (1.00) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL5306820 0.76 KMT2A (0.80) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL5306824 0.76 KMT2A (0.80) KMT2ADNMT1CYP2C19DNMT3BPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007007054-A1 PHTHALAMIDES, SUCCINIMIDES AND RELATED COMPOUNDS AND THEIR USE AS PHARMACEUTICALS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-01-18 — — WO disclosed
Send feedback